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Objective: Radiofrequency catheter ablation for persistent atrial fibrillation (PeAF) still
has a substantial recurrence rate. This study aims to investigate whether an AF ablation
lesion set chosen using in-silico ablation (V-ABL) is clinically feasible and more effective
than an empirically chosen ablation lesion set (Em-ABL) in patients with PeAF.
Methods: We prospectively included 108 patients with antiarrhythmic drug-resistant
PeAF (77.8% men, age 60.8 ± 9.9 years), and randomly assigned them to the V-ABL
(n = 53) and Em-ABL (n = 55) groups. Five different in-silico ablation lesion sets [1
pulmonary vein isolation (PVI), 3 linear ablations, and 1 electrogram-guided ablation] were
compared using heart-CT integrated AF modeling. We evaluated the feasibility, safety,
and efficacy of V-ABL compared with that of Em-ABL.
Results: The pre-procedural computing time for five different ablation strategies was
166 ± 11min. In the Em-ABL group, the earliest terminating blinded in-silico lesion set
matched with the Em-ABL lesion set in 21.8%. V-ABL was not inferior to Em-ABL in
terms of procedure time (p = 0.403), ablation time (p = 0.510), and major complication
rate (p = 0.900). During 12.6 ± 3.8 months of follow-up, the clinical recurrence rate was
14.0% in the V-ABL group and 18.9% in the Em-ABL group (p = 0.538). In Em-ABL
group, clinical recurrence rate was significantly lower after PVI+posterior box+anterior
linear ablation, which showed the most frequent termination during in-silico ablation
(log-rank p = 0.027).
Conclusions: V-ABL was feasible in clinical practice, not inferior to Em-ABL, and
predicts the most effective ablation lesion set in patients who underwent PeAF ablation.
Keywords: atrial fibrillation, catheter ablation, virtual ablation, in-silico modeling, recurrence
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INTRODUCTION
The prevalence of AF increases with age, and ∼20% of all
ischemic strokes are associated with AF (Goldstein et al., 2011).
It is predicted that the prevalence of AF would more than double
by the year 2050 (Ball et al., 2013). Although radiofrequency
catheter ablation (RFCA) has been established as an effective
rhythm control strategy, it still has a substantial long-term
recurrence rate, especially in patients with persistent AF (Dewire
and Calkins, 2013). AF catheter ablation introduces the risk of
collateral damages, and a long duration of ablation procedure
is associated with poor clinical outcomes (Shim et al., 2013).
Moreover, the ablation strategy is selected largely based on the
physician’s experience, which bears the possibility of outcome
differences depending on the physician. On the other hand,
computer simulation has been widely used in the study of
the mechanisms of AF (Hwang et al., 2014; Trayanova, 2014).
Recently, a number of attempts have been made to use computer
simulation for studying the effects of catheter ablation (Zhao
et al., 2015). We previously conducted a retrospective study
and reported that the earliest virtual AF terminating lesion
set chosen by using a computer was commonly identical to
that selected by the physician who performed the ablations in
patients with persistent AF (Hwang et al., 2014). Because the
computing speed for complicated in-silicomodeling of AF is one
of the limitations for the application of computer simulation
in clinical practice, we have shortened the computing time for
AF modeling by about 80 times compared with conventional
modeling (Hwang et al., 2015; Zhao et al., 2015). This study
was a prospective randomized trial to examine the applicability,
safety, and efficacy of computer simulation for catheter ablation
of AF. The ablation strategy was selected on the basis of
computer simulation for one group of patients, and according
to the physician’s experience for the other group. Then, we
evaluated the feasibility of in-silico ablation (computing time),
and compared procedure time, procedure related complication
rate, long-term rhythm outcome of both groups, and the most
effective lesion set in in-silico ablation and empirical ablation
(Em-ABL).
METHODS
Study Design
The study protocol adhered to the Declaration of Helsinki and
was approved by the institutional review board of the Yonsei
University Health System (clinicaltrials.gov; NCT 02171364).
The enrolled patients were randomly assigned to either the virtual
ablation (V-ABL) group or the Em-ABL group (Figure 1). For
all patients in both groups, virtual ablations were performed by
applying the following 5 strategies: (i) circumferential pulmonary
vein isolation (CPVI), (ii) CPVI + posterior box lesion, (iii)
CPVI + posterior box lesion + anterior line, (iv) CPVI +
roof line + left lateral isthmus line, and (v) CPVI + complex
fractionated atrial electrogram (CFAE)-guided ablation (Hwang
et al., 2014; Song et al., 2016). For patients in the V-ABL group,
the best virtual ablation strategy was applied in real ablation. The
virtual ablation strategy that resulted in the earliest termination
FIGURE 1 | Study flow chart. The enrolled patients were randomly assigned to
either the virtual ablation (V-ABL) group or the empirical ablation (Em-ABL)
group. Virtual ablations were performed for all patients in both groups, by
applying five strategies. For patients in the V-ABL group, the best virtual
ablation strategy was applied in real ablation. For patients in the Em-ABL
group, the ablation strategy selected by the physician based on experience
was applied in real ablation. The ablation outcomes were compared between
the V-ABL and Em-ABL groups.
of AF after in-silico ablation was determined as the best in-silico
ablation lesion set among the five ablation strategies. For patients
in the Em-ABL group, the ablation strategy selected by the
physician based on experience was applied in real ablation. The
ablation outcomes were compared between the V-ABL and Em-
ABL groups.
Study Population
In this study, we enrolled 118 patients with persistent AF
(PeAF) who were eligible for RFCA. All patients provided written
informed consent. The inclusion criteria were (i) age 19 years or
older, (ii) antiarrhythmic drug resistance, and (iii) availability of
three-dimensional (3D) computed tomography (CT) ormagnetic
resonance imaging (MRI) scans of the left atrium (LA). The
exclusion criteria were (i) presence of significant structural heart
disease, (ii) valvular AF, (iii) previous ablation or cardiac surgery,
and (iv) presence of a cardiac implantable electronic device.
After receiving the patients’ consent, DICOM files of heart
CT were sent to the core laboratory a night before or
in the early morning of the real AF ablation procedure.
Patient randomization, in-silico AF modeling, and virtual AF
ablation were done at the core laboratory during work hours
(9.a.m.–6 p.m.). Among 118 patients, four were excluded owing
to incorrect patient selection or patient request. Additional six
patients were excluded because of failed in-silico AF ablation
before the real ablation procedure, due to DICOM file error
(n = 2) and communication error (n = 4). Finally, 108 patients
(53 in the V-ABL group and 55 in the Em-ABL group) were
enrolled in this study (Figure 1). The patient characteristics are
shown in Table 1.
In-Silico Simulation of AF
Atrial geometries were reconstructed from the 3D CT merged
NavX data (NavX; St. Jude Medical Inc., Minnetonka, MN,
USA) defining the surface of the atrium. A triangular mesh was
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TABLE 1 | Patient characteristics.
Overall V-ABL Em-ABL p-Value
(N = 108) (N = 53) (N = 55)
Age (years) 60.8 ± 9.6 59.7 ± 10.1 61.9 ± 9.6 0.240
Male (%) 76.9 75.5 78.2 0.821
Longstanding
persistent AF (%)
77.8 83.0 72.7 0.249
CHA2DS2-VASc
score
1.97 ± 1.86 1.85 ± 1.65 2.09 ± 1.86 0.475
Heart failure (%) 12.0 9.4 14.5 0.557
Hypertension (%) 54.6 52.8 56.4 0.847
Age > 75 years (%) 9.3 3.8 14.5 0.094
Age 65–74 years (%) 25.0 28.3 21.8 0.508
Diabetes (%) 18.5 17.0 20.0 0.806
Previous stroke (%) 28.7 28.3 29.1 1
Previous TIA (%) 1.9 3.8 0 0.238
Vascular disease (%) 13.0 9.4 16.4 0.392
ECHOCARDIOGRAPHIC FINDINGS
LA dimension (mm) 45.1 ± 4.4 46.1 ± 7.6 44.0 ± 4.4 0.086
EF (%) 59.3 ± 9.7 57.8 ± 7.8 60.7 ± 9.7 0.092
E/Em 10.2 ± 4.7 9.6 ± 3.0 10.7 ± 4.7 0.139
TIA, transient ischemic attack; LA, left atrium; EF, ejection fraction; E/Em, the ratio of early
transmitral flow velocity (E) to early mitral annular velocity (Em).
generated on the surface of the 3D atrial geometry. The final
number of grid elements was between 400,000 and 500,000. The
LA appendage andmyocardial sleeves were included in the mesh.
For the simulation of cardiac wave propagation in the atrial wall,
the following reaction-diffusion equation was solved numerically
(Zozor et al., 2003):
∂Vm
∂t
=
1
βCm
{∇ · D∇Vm − β (Iion + Is)} , (1)
where Vm is the membrane potential (Unit: volt); β is the
membrane surface-to-volume ratio (Unit: meter−1); Cm is the
membrane capacitance per unit area (Unit: farad/meter2); D
is conductivity tensor (Unit: siemens/meter); and Iion and Is
are the ion current and stimulation current, respectively (Unit:
ampere/meter2).
For the calculation of ionic currents, a mathematical model of
human atrial action potential proposed by Courtemanche et al.
(1998) was used. Electrical stimulation was applied at the location
of Bachmann’s bundle, and reentry was initiated by rapid pacing:
a total of 24 pacings with pacing cycle lengths of 200, 190, and
180ms. To induce self-sustained fibrillation, Ito, ICaL, and IKur
were reduced by 80, 40, and 50%, respectively, and IK1 was
increased by 50% (Li et al., 2016).We chose a conduction velocity
of 0.4 m/s based on real human patient data (Yonsei AF ablation
cohort data; n= 1,980; mean CV= 0.43± 0.24 m/s) (Park et al.,
2014) and previous simulation studies (Hwang et al., 2014; Li
et al., 2016).
Virtual AF Ablation
Virtual ablation was conducted for all patients in both the V-ABL
and Em-ABL groups. We developed a graphical user interface
software with which the user can perform virtual ablation by
mouse-clicking on the atrial geometry (CUVIA, Model: SH01,
ver. 1.0; Laonmed Inc., Seoul, Korea; Figure 2). At the point
where the mouse is clicked, a 2-mm-diameter circular region is
virtually ablated, mimicking real ablation with a radiofrequency
catheter. In the ablated region, no electrical flux condition was
applied. The pattern of ablation was completed by serial mouse-
clickings, similarly to real catheter ablation. For CFAE-guided
ablations (Nademanee et al., 2004), the areas with CFAE cycle
length < 120ms were ablated as long as the total ablated area is
< 5% of the whole atrial area. CFAE was observed in particular
region in structurally homogenous simulation due to the three-
dimensional geometrical variation. The area where the mitral
annulus was located was also considered a non-conductive area.
Virtual ablation was applied at 4 s after the end of pacings, and
the simulation was run until 25 s from the start of the simulation.
When all points in the atrial wall were repolarized by > 90%,
the fibrillation was considered terminated. The duration until
the termination of fibrillation was recorded for each ablation
strategy for each patient. NavX potential map was not used in the
virtual ablation. The physicians, however, utilized the endocardial
potential map data in their decision makings. Fiber orientation
was not considered in the simulation model, and conductivity
was isotropic even though three-dimensional geometrical shape
may have affected conductivity.
Real AF Ablation
The electrophysiological mapping method and the RFCA
technique were as described previously (Mun et al., 2012). Briefly,
we used an open irrigated-tip catheter (Celsius [Johnson &
Johnson Inc., Diamond Bar, CA, USA] or Coolflex [St. Jude
Medical]; 30–35W, 47◦C) to deliver radiofrequency energy for
ablation under 3D electroanatomical mapping (NavX, St. Jude
Medical; CARTO3, Johnson & Johnson) merged with 3D spiral
CT. The procedure was completed when there was no immediate
recurrence of AF after cardioversion with isoproterenol infusion
(5µg/min). All RFCA procedures were performed by an operator
with> 10 years of experience.
Post-ablation Management and Follow-Up
As per RFCA procedure protocols, antiarrhythmic drugs were
discontinued in all patients. The patients visited the outpatient
clinic at 1, 3, 6, and 12 months after RFCA, or whenever
symptoms occurred. All patients underwent electrocardiography
at each visit, and 24-h Holter recording was done at 3,
6, and 12 months, according to the 2012 Heart Rhythm
Society/European Heart Rhythm Association/European Cardiac
Arrhythmia Society Expert Consensus Statement (Calkins et al.,
2012). However, whenever patients reported palpitations, Holter
monitor or event monitor recordings were obtained and
evaluated to check for arrhythmia recurrence. We defined
recurrence of AF as any episode of AF or atrial tachycardia lasting
for at least 30 s. Any electrocardiography documentation of AF
recurrence after 3 months of the blanking period was diagnosed
as clinical recurrence.
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FIGURE 2 | Virtual ablation procedure. Computed tomography images are segmented to construct three-dimensional atrial geometry. Virtual atrial fibrillation (AF) is
induced. The maps of cardiac wave dynamics parameters such as complex fractionated atrial electrogram (CFAE) are generated. Virtual ablation is performed on the
atrial geometry. AF simulation is resumed. The cardiac wave propagation pattern is observed.
Statistical Analysis
Because the trial was conducted as a pilot study, the sample
size was driven by the computation time and feasibility of
recruiting eligible patients, and enrollment was open for 12
months. Results are expressed as mean values ± standard
deviation for continuous variables, and absolute number and
percentages for categorical variables. Continuous variables were
compared by using Student’s t-test, and categorical variables were
compared by using either the chi-square test or Fisher’s exact
test as appropriate. The primary end point of the study was
freedom from any atrial arrhythmias during follow-up after a 3-
month blanking period. The time to recurrence and arrhythmia-
free survival were assessed by using Kaplan-Meier analysis, and
differences were calculated by using the log-rank test. A p-value
of < 0.05 was considered statistically significant. All statistical
analyses were performed by using SPSS version 18.0 software
(SPSS Inc., Chicago, IL, USA).
RESULTS
Patient Characteristics
The patients’ characteristics are summarized in Table 1. The
mean age was 60.8 ± 9.6 years, and 76.9% were male patients.
Among 108 patients with PeAF, 77.8% had longstanding PeAF
(lasting for >1 year). More than 28% of patients had a history of
stroke or transient ischemic attack; the mean left atrial dimension
was 45.1 ± 4.4mm and the mean ejection fraction was 59.3 ±
9.7%. Randomization was done well, and there was no statistically
significant difference between the V-ABL and Em-ABL groups.
In-Silico Ablation Results
In-silicoAF ablations were done in all included patients; however,
the Em-ABL group was blinded to the in-silico ablation results.
The pre-procedural computing time for the five virtual ablation
strategies described in the Methods section was 166 ± 11min.
Heart CT segmentation with a semi-automatic method and
five different in-silico ablation lesion settings with the manual
method took about 1 h. Another 1 h was taken for computing
the five different in-silico ablation protocols simultaneously, and
additional 30min was required for the calculation of the CFAE
area.
Table 2 summarizes the outcome of in-silico AF ablation.
After virtual ablation, we waited for 25 s, measuring the
termination time. Among the five in-silico ablation strategies,
[CPVI+Posterior box+Anterior linear ablation] showed the
highest AF termination rate (81.5%, 88 of 108) and shortest time
to AF termination (16.792 ± 5.672ms). The AF termination
rates within 25 s were 73.1% after [CPVI+Roof line+Left lateral
isthmus] in-silico ablation, 28.7% after [CPVI+Posterior box]
after in-silico ablation, 11.1% after [CPVI only], and 8.3% after
[CPVI+CFAE] virtual ablation. Compared with virtual [CPVI
only], virtual [CPVI+Posterior box+Anterior line] (p < 0.001)
and virtual [CPVI+Roof line+Left lateral isthmus line] (p <
0.001) showed significantly higher virtual AF termination rates
in both the V-ABL and Em-ABL groups. There was no significant
difference in the in-silico ablation outcome between the V-ABL
group and the Em-ABL group.
Comparison of V-ABL and Em-ABL
In the real ablation procedure, CPVI only was more commonly
chosen in the Em-ABL group (30.9%) than in the V-ABL group
(1.9%, p < 0.001; Table 3). Among patients in the V-ABL group,
[CPVI+Roof+Left lateral isthmus] ablation wasmost commonly
chosen (43.4%), although in-silico AF termination rate was
highest in [CPVI+Posterior box+Anterior line] (Table 2). This
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TABLE 2 | Virtual ablation outcome.
Overall V-ABL Em-ABL p-Value
(N = 108) (N = 53) (N = 55)
Conduction
velocity (m/s)
0.41 ± 0.11 0.40 ± 0.07 0.41 ± 0.14 0.615
APD90 (ms) 213 ± 2 213 ± 2 213 ± 3 0.618
AF TERMINATION RATE (%)
CPVI 11.1 (12/108) 9.4 (5/53) 12.7 (7/55) 0.761
CPVI + PostBox 28.7 (31/108)* 34.0 (18/53)† 23.6 (13/55) 0.289
CPVI + PostBox
+ AL
81.5 (88/108)* 83.0 (44/53)† 80.0 (44/55)‡ 0.806
CPVI + RL + LLI 73.1 (79/108)* 75.5 (40/53)† 70.9 (39/55)‡ 0.667
CPVI + CFAE 8.3 (9/108) 7.5 (4/53) 9.1 (5/55) 1.000
TIME TO AF TERMINATION (MS)
CPVI 23914 ± 3466 24017 ± 3354 23815 ± 3599 0.763
CPVI + PostBox 21893 ± 5471 21463 ± 5719 22307 ± 5240 0.426
CPVI + PostBox
+ AL
16792 ± 5672 16478 ± 5750 17094 ± 5633 0.575
CPVI + RL + LLI 17701 ± 5770 17199 ± 5949 18185 ± 5604 0.378
CPVI + CFAE 24170 ± 3041 24319 ± 2686 24018 ± 3385 0.619
*p < 0.001, †p < 0.001, ‡p < 0.001 compared with the CPVI of each group.
APD90, action potential duration of 90% repolarization; CPVI, circumferential pulmonary
vein isolation; PostBox, posterior box isolation; AL, anterior line; RL, roof line; LLI, left
lateral isthmus line; CFAE, complex fractionated atrial electrogram guided ablation.
was because, when AF was terminated in both lesion sets (32
cases), we chose the earliest terminating virtual lesion set (16 in
[CPVI+Roof+Left lateral isthmus] and 11 in [CPVI+Posterior
box+Anterior line]). In the Em-ABL group, [CPVI+Posterior
box+Anterior line] was selected most often (36.4%), followed by
[CPVI only] (30.9%; p= 0.687) (Table 3). Among patients in the
Em-ABL group, the earliest terminating in-silico lesion set, which
was blinded to the operator, was identical to the empirically
chosen real ablation lesion set in 21.8% (12 of 55).
The procedure-related acute outcomes are summarized in
Table 3. There was no significant difference in procedure
time (p = 0.289), ablation time (p = 0.988), complication
rates (p = 0.359), and early recurrence rate within 3 months
(p= 1.000) between the V-ABL group and the Em-ABL group.
Comparison of Rhythm Outcomes
During 12.6 ± 3.8 months of follow-up, the clinical recurrence
rates were 14.0% in the V-ABL group and 20.9% in the Em-
ABL group (p= 0.411). The maintenance rates of antiarrhythmic
drugs were 49.1% in the V-ABL group and 39.5% in the Em-ABL
group (p = 0.840). Kaplan-Meier analyses showed consistent
findings in the overall patients (log-rank p = 0.732; Figure 3A)
and after excluding patients who maintained antiarrhythmic
drugs (log-rank p= 0.751; Figure 3C).
However, when we compared the clinical recurrence rate
according to the ablation lesion set, the clinical recurrence
rates were significantly lower in patients in the Em-ABL group
who underwent [CPVI+Posterior box+Anterior line] ablation,
which showed the most frequent termination and shortest AF
TABLE 3 | Clinical outcome.
Overall V-ABL Em-ABL p-Value
(N = 108) (N = 53) (N = 55)
PROCEDURAL LESION SET (%)
CPVI 16.7 (18/108) 1.9 (1/53) 30.9 (17/55) < 0.001
CPVI + PostBox 6.5 (7/108) 11.3 (6/53) 1.8 (1/55) 0.058
CPVI + PostBox
+ AL
38.0 (41/108) 39.6 (21/53) 36.4 (20/55) 0.843
CPVI + RL + LLI 33.3 (36/108) 43.4 (23/53) 23.6 (13/55) 0.041
CPVI + CFAE 5.6 (6/108) 3.8 (2/53) 7.1 (4/56) 0.679
Procedure time
(min)
263.5 ± 88.5 256.2 ± 69.0 271.5 ± 104.7 0.403
Ablation time
(min)
5121.9 ± 2574.6 4954.7 ± 2804.0 5272.8 ± 2368.2 0.510
Fluoroscopic
time (min)
57 ± 30 59 ± 31 55 ± 30 0.523
Complication
rate (%)
4.2 4.4 4.0 0.900
AAD utilization
rate (%)
42.6 49.1 36.4 0.320
Early recurrence
(%)
30.2 33.3 27.3 0.531
Clinical
recurrence (%)
16.0 14.0 18.9 0.538
CPVI, circumferential pulmonary vein isolation; PostBox, posterior box isolation; AL,
anterior line; RL, roof line; LLI, left lateral isthmus line; CFAE, complex fractionated atrial
electrogram guided ablation; AAD, antiarrhythmic drug.
maintenance duration in virtual ablation (log-rank p = 0.027;
Figure 4).
DISCUSSION
Main Findings
In this prospective randomized trial, we investigated the
feasibility of using a virtual ablation system in clinical practice
and compared the clinical outcome of simulation-guided ablation
(V-ABL) with empirical ablation (Em-ABL) in patients with
PeAF. Patient-specific atrial geometry was used for finite element
modeling, and five different virtual ablation patterns were
tested for each patient. This is the first randomized study to
validate the clinical outcomes of simulation-guided ablation,
demonstrating the potential of in-silico computer models for
planning individualized ablation strategies in clinical practice.
We demonstrated that the most effective in-silico AF ablation
lesion set showed the best clinical outcome in the Em-ABL group.
The overall safety and efficacy of simulation-guided intervention
was not inferior to empirical ablation of PeAF.
Unmet Clinical Needs in PeAF Ablation
Although pulmonary vein isolation is the cornerstone of catheter
ablation for AF and effective in patients with paroxysmal AF,
this was found to be insufficient to treat longstanding persistent
AF. Even in the STAR AF II trial (Verma et al., 2015), which
advocated CPVI alone for PeAF, a 41% recurrence rate within
18 months of CPVI procedure was not good enough for clinical
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FIGURE 3 | Kaplan-Meier curves. (A) Overall patients. (B) Patients maintaining antiarrhythmic drug use were excluded.
FIGURE 4 | Kaplan-Meier curves comparing the clinical recurrence rate of patients who underwent circumferential pulmonary vein isolation (CPVI) + posterior box
lesion + anterior line with that of the other patients. (A) Overall patients. (B) V-ABL group. (C) Em-ABL group.
practice. However, there is no consensus on further ablation after
CPVI in PeAF (Verma et al., 2015). Linear ablation modifies the
atrial substrates and compartmentalizes the atrium into smaller
regions to reduce critical mass and AF maintenance (Pak et al.,
2011). The question on what is the best linear lesion set for
individual patients remains unanswered. CFAE ablation has been
reported to be effective for substrate modification in PeAF by
some investigators (Nademanee et al., 2004; Verma et al., 2010);
however, this positive outcome was not reproduced in other
investigations (Oral et al., 2008). Other various ablation strategies
targeting rotor (Narayan et al., 2012), driver (Haissaguerre
et al., 2014), dominant frequency (Atienza et al., 2014), or
Shannon entropy (Ganesan et al., 2013) remain to be validated
in patients with PeAF. There are potential explanations for
the lack of a “one-fits-all ablation protocol.” First, PeAF is a
progressive disease with various stages, and its nature is affected
by the anatomy, histology, electrophysiology, and hemodynamic
loading of individual patients. Second, the AF ablation procedure
is operator dependent and the outcome is affected by the ablation
lesion set; catheter stability; or ablation power, duration, and
contact force. Third, it is not possible to test three different
ablation designs in a patient because radiofrequency ablation
causes irreversible tissue change. Therefore, in-silico AF ablation
might be useful to test several different ablation lesion sets in a
personalized modeling approach reflecting anatomy, histology,
electrophysiology, and even genetic characteristics (Hwang et al.,
2014).
Roles and Limitations of In-Silico AF
Ablation
The advantage of computer simulation modeling is the potential
for direct comparison of different ablation strategies for
individual pre-procedural planning. As a result, modeling is
emerging as a complementary approach to animal experiments
and clinical trials in investigating more effective treatment
(Winslow et al., 2012). Previously, Ruchat et al. (2007) compared
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the success rates in converting AF to sinus rhythm for 19
different linear ablation patterns by using a single identical
human atrial model. There have been six AF simulation studies
of catheter ablation thus far (Jacquemet, 2016), and we previously
reported on multiple virtual ablation protocols in 20 different
personalized human atrial models (Hwang et al., 2014). In this
study, we conducted in-silico ablations prospectively in 108
personalized LA models reflecting individual anatomy; however,
it was also a single-layer homogeneous modeling approach
without integrating local histology. The main reason for our
use of over-simplified simulation modeling was to reduce the
computing time. Unless AF simulation and virtual intervention
can generate the result within a few hours, it is not acceptable
for clinical application during intervention. Although we already
made the computing time 80 times faster by using a graphics
processing unit system, further innovation is still needed for
sophisticated realistic AF modeling reflecting detailed histology
and electrophysiology.
Another discrepancy of in-silico AF ablation and real catheter
ablation is completeness and maintenance of conduction block
after linear ablation. Although [CPVI+Posterior box+Anterior
linear ablation] showed the highest antifibrillatory effect in
both virtual ablation and Em-ABL, it was difficult to achieve
complete and permanent transmural conduction block by using
endocardial radiofrequency energy delivery in the clinical setting
with a beating heart and respiratory motion. A non-transmural
lesion or ablation gap provides one of the main reasons for AF
recurrence after an ablation procedure, discordant to in-silico AF
ablation.
Study Limitations
There are limitations in our simulation modeling. The
mechanism of AF in this particular computer model is based
exclusively on multiple wavelet theories (Moe et al., 1964), and
other well-described mechanisms like rotors can be masked in
this model. Although we used patient-specific atrial geometry for
the AF ablation simulation, individual electrophysiological and
structural characteristics such as regional differences in action
potential morphology, and fiber orientation were not included.
Clinical studies showed that atrial wall thickness affected AF
wave dynamics (Song et al., 2017), but the wall thickness was
not considered in the present model. We also did not model
the right atrium, because AF drivers have been known to exist
mostly in the LA in humans (Sanders et al., 2005). We assume
that the predictability of AF intervention by using simulation
will be improved remarkably by integrating high-resolution
cardiac imaging modalities reflecting the remodeled scar area,
pathological electro-anatomical information acquired during
procedure, andmore realistic multilayer bi-atrial modeling study.
Although our modeling protocol for virtual AF ablation may not
reflect the mechanism of AF ablation precisely (whether virtual
ablation stops an ongoing AF or whether it hinders the onset
of new episode of AF, ectopic centers, rotor, or micro-reentry,
etc.), it exhibits the antiarrhythmic effects of appropriate critical
mass reduction, which is the main antiarrhythmic mechanism
of linear ablation of AF or a surgical maze procedure. While
CV may also change AF wave dynamics, we used a fixed CV
based on real human patient data (Yonsei AF ablation cohort)
(Park et al., 2014) and previous simulation studies (Hwang
et al., 2014; Li et al., 2016). Because we tested five different
virtual ablation protocols in every patient’s LA modeling at the
same CV condition, it did not affect the mechanism of critical
mass reduction. For the model to show superiority to empirical
ablation, individual patient’s structural heterogeneity such as
scar/fibrosis, fiber orientation, and wall thickness variation
should be included in the model.
CONCLUSION
This is the first randomized multicenter study to demonstrate
that simulation-guided ablation by using personalized models
of LA was feasible, and the clinical outcome was not inferior
to that of empirical ablation. Although there are limitations in
applying virtual AF ablation to a personalized ablation strategy,
our results showed that the virtual AF ablation system is capable
of identifying the most effective ablation lesion set for individual
patients. Advances in modeling technology might provide useful
clinical insights for planning therapeutic interventions in the
near future.
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